The intricacies of immunomodulation in clinical trials can be complex, but our latest issue of The Altascientist breaks them down for you, including the standard classes of immunomodulators, advanced bioanalytical methods, and case studies with practical insights. Whether you focus on PK/PD studies or assess safety, we provide the strategies you need for reliable, actionable results. #DrugDevelopment #ClinicalTrials #Bioanalysis
Altasciences’ Post
More Relevant Posts
-
The intricacies of immunomodulation in clinical trials can be complex, but our latest issue of The Altascientist breaks them down for you, including the standard classes of immunomodulators, advanced bioanalytical methods, and case studies with practical insights. Whether you focus on PK/PD studies or assess safety, we provide the strategies you need for reliable, actionable results. Read it now: https://lnkd.in/grA_ep5F #DrugDevelopment #ClinicalTrials #Bioanalysis
To view or add a comment, sign in
-
-
Want to learn more about the regulatory considerations for PK bioanalysis? Look no further and watch our on-demand panel discussion: overcoming the unique bioanalytical challenges of supporting complex, regulated clinical studies now >>> https://hubs.ly/Q02KcPv80
To view or add a comment, sign in
-
🎉🎉🎉 Phase 2a trial update 🎉🎉🎉 We have achieved last patient last visit on our ongoing phase 2a weight-loss clinical trial. The data is now being cleaned. WATCH THIS SPACE. #biotech #obesity #lifesciences #clinical #weightloss #phase2 #trial
To view or add a comment, sign in
-
-
Getting to grips with clinical trials: how can start-ups ensure bioanalyticalsis success? Tom Zhang, Worldwide Clinical Trials' CSO of Large Molecule Bioanalysis, details the need for bioanalytical and clinical expertise to meet assay requirements, and shares strategies for overcoming clinical trial bottlenecks >>> https://hubs.ly/Q02HM5-D0
To view or add a comment, sign in
-
Scientists recently developed a high performance liquid chromatography–ultraviolet (HPLC–UV) method for measuring selpercatinib blood levels in hopes of simplifying therapeutic drug monitoring in clinical practice. Link: https://lnkd.in/dFtzVUtE
To view or add a comment, sign in
-
-
Hear from the 2024 Annual Meeting's Abstract Directors, Hannah Zierden, PhD, and Alexandros Marios Sofias, PhD, as they highlight the incredible stats we've seen with this year's abstract submissions. You can view the full Abstract topics overview here: https://ow.ly/ig0B50SmIFU #CRS2024 #deliveryscience #pharma #drugdelivery #scientist #scienceandtechnology #researchandevelopment
To view or add a comment, sign in
-
Stay in the loop! Explore how LC–MS, LBA and hybrid assays are currently being used to support clinical trials from a bioanalytical perspective, and their advantages and drawbacks in our upcoming panel discussion! Register now >>> https://hubs.ly/Q02KcT8_0
To view or add a comment, sign in
-
Understanding suitable bioanalytical approaches is critical with the rapid development of mRNA-based treatments. Check out our on-demand webinar for a deep dive into the strategies and challenges in bioanalysis for LNP-mRNA products. https://hubs.ly/Q02TTtll0
To view or add a comment, sign in
-
-
Understanding suitable bioanalytical approaches is critical with the rapid development of mRNA-based treatments. Check out our on-demand webinar for a deep dive into the strategies and challenges in bioanalysis for LNP-mRNA products. https://hubs.ly/Q02TTvgd0
To view or add a comment, sign in
-
-
Here is a link to Domainex's recent med chem blog reviewing Genetech's recent paper on the discovery of GNE7599. I hope you find it useful.
At #Domainex we are always searching the literature to keep on top of the latest developments. In the latest edition of our "Medicinal Chemistry in Review" blog series, the focus was on a paper from Genentech which discloses the discovery of GNE7599, a VHL ligand with improved potency and cellular permeability and good oral bioavailability. https://lnkd.in/enp8JRFj We hope you enjoy reading it. #DrugDiscovery #MedChem
To view or add a comment, sign in
-
More from this author
-
Best Practices for Preclinical Dose Range Finding Studies
Altasciences 3d -
Guest Article: Forging a Path Forward for Substance Abuse Potential Studies With the Cross-Company Abuse Liability Council, by Beatrice Setnik, PhD
Altasciences 1mo -
How Improving Diversity Can Benefit Clinical Trials
Altasciences 1mo